“…Similarities in cellular composition and architecture between the in vitro organotypic brain slice cultures and the in vivo setting offer advantages to model complex brain physiology and pathophysiology even though a detailed characterization of the cellular and molecular features of the brain slice culture system was lacking as it pertains to microglia properties in this experimental system. These presumed similarities prompted many studies using variants of the brain slice culture platform to study pathogenic mechanisms involved in stroke, epilepsy, neurodegenerative proteinopathies, and responses to specific neuroinflammatory stimuli (Bernardino, 2005 ; Vinet et al, 2012 ; Ziemka-Nałecz et al, 2013 ; Olajide et al, 2014 ; Hellwig et al, 2015 ; Gerlach et al, 2016 ; Masuch et al, 2016a , b ; Bhatia et al, 2017 ; Saliba et al, 2017 ; Yousif et al, 2018 ; Araki et al, 2019 ; Croft et al, 2019a ; Grabiec et al, 2019 ; Richter et al, 2019 ; Sheppard et al, 2019 ). Revisiting these studies in light of our results may reveal new insights into the role of microglia in these settings.…”